Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Potassium Channel
    (5)
Filter
Search Result
Results for "

kv7.2 (kcnq2) channels

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    5
    TargetMol | Inhibitors_Agonists
ZTZ240
ZTZ-240, ZTZ 240
T29236325457-98-5In house
ZTZ240 is a KCNQ2 channel activator used in the study of epilepsy.
  • $293
In Stock
Size
QTY
TargetMol | Citations Cited
XE 991 dihydrochloride
T17262122955-13-9
XE 991 dihydrochloride is a Kv7 (KCNQ) channel blocker. XE 991 dihydrochloride potently inhibits Kv7.1 (KCNQ1), Kv7.2 (KCNQ2), Kv7.2 + Kv7.3 (KCNQ3) channel, and M-current (IC50s: 0.75 μM, 0.71 μM, 0.6 μM, and 0.98 μM, respectively).
  • $41
In Stock
Size
QTY
ML213
CID-3111211
T4030489402-47-3
ML213 (CID-3111211) is a selective activator of Kv7.2 (KCNQ2) and Kv7.4 (KCNQ4) channels, enhances Kv7.2 and Kv7.4 channels with EC50s of 230 and 510 nM, respectively.
  • $34
In Stock
Size
QTY
XE991
T78570122955-42-4In house
XE991 is a novel and selective Kv7 (KCNQ) channel blocker.XE 991 dihydrochloride inhibits Kv7.1 (KCNQ1), Kv7.2 (KCNQ2), Kv7.2 + Kv7.3 (KCNQ3) channels, and M-current, and can be used for the study of neurological diseases.
  • $35
In Stock
Size
QTY
TargetMol | Citations Cited
Kv7.2/Kv7.3 agonist 1
T2010632315450-35-0
Kv7.2/Kv7.3 agonist 1 (Compound 16) is an orally effective agonist for the KV7.2/7.3 channels (KV7.2/7.3 channel/KCNQ2/3) with an EC50 of 1.03 μM. This compound demonstrates analgesic effects in mouse models of chronic constriction injury (CCI) and Streptozotocin-induced diabetic peripheral neuropathy (DPNP), with ED50 values of 12.02 mg/kg and 9.63 mg/kg, respectively.
  • $1,520
4-6 weeks
Size
QTY